Journal Article10.1038/ajg.2016.356
Esophagus
Evan S. Dellon,Margaret S. Collins,Y. Assouline-Dayan,Larry Evans,Sandeep K. S. Gupta,Alain M. Schoepfer,Alex Straumann,Michael Grimm,H. Smith,Cindy-ann Tompkins,Amy Woo,R. Peach,Paul A. Frohna,S. Gujrathi,Richard Aranda,Allan Olson,D. Penenberg,Ikuo Hirono +17 more
- Vol. 111, pp S186-S235
2
About: This article is published in The American Journal of Gastroenterology.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Eosinophilic esophagitis: short and long-term considerations.
TL;DR: EoE has been increasingly recognized as a cause of food impactions and dysphagia and shorter-term treatment goals include symptomatic and histological improvement, with prevention of fibrostenotic disease the primary long-term goal.
6
The role of dupilumab in diverse allergic pathologies
14 Jun 2023
TL;DR: Dupilumab as mentioned in this paper is designed to inhibit the signaling chain of IL-3 and IL-4, more specifically, it binds to the α receptor of IL 4 and the cytokine-induced receptor complex IL 13 through receptor 1, stopping the release of IgE and proinflammatory cytokines.